Fresh analysis indicates that patients who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover lost weight far faster than those who stop conventional lifestyle regimens.
Findings released in a major medical journal shows that while obese people frequently drop substantial amounts of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users purchasing such treatments must be cognizant of the risk of rapid rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.
This pace of regain means a return to pre-treatment mass within about a year and a half.
Analyzing Approaches
The research, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone typically see a less rapid weight regain—around 100 grams monthly—once they finish.
Explaining the Quick Rebound
Doctors propose the mechanism of the injections is key to understanding the amplified rebound.
These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the system to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making binge eating far more likely."
A Lifelong Issue?
The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals argue that, considering the likelihood of weight regain, the treatment should be considered ongoing.
This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like diabetes.
User Testimonies
People who have come off the medication report a sudden return of cravings.
"It felt as if a trigger flipping and you're instantly extremely hungry," said one woman.
This challenge is exacerbated if users have not established lasting lifestyle or habit modifications during treatment.
Growing Interest
Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with demand being substantial.
- Use is more common among females compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, experts stress that while the jabs are effective agents for shedding pounds, they are not a standalone fix and long-term success relies on combined behavioural changes.
